(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EITAN MEDICAL AVOSET

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

EITAN MEDICAL AVOSET

ST13

US500000079310933

Class

10

Filing

79310933

Registration

6881835

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

50

Latest update

04/12/2024

Trademark type

Combined

Nice classes

10

Filing date

02/14/2021

Registration date

10/25/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/25/2022

Last transaction

10/25/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

03

Owner location

IL

Examiner

SOUDERS, MICHAEL J

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "EITAN MEDICAL AVOSET" stacked vertically. To the left of the wording are two circles appearing above an infinity symbol.

Holders and representatives

Holders

Eitan Medical Ltd

Representatives

Avital (Tally) Eitan GORNITZKY & CO.

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Medicalveterinary and surgical apparatus and instrumentsinfusion and injection devices for administering fluiddrugs and nutrition and parts and accessories for use with these instruments; Drug delivery devices and their compatible disposablessold emptysyringesinfusion setsfilling bagscartridgesadministration setsconnectorstubingcassettespumping connectorsvalvesfilters for carrying and delivering pharmaceuticalsfluidsdrugs and nutrition for medical treatment with integrated recorded software for monitoringtrackinggatheringtransmittingcontrollingprocessingmeasuring and managing data regarding the delivery of pharmaceuticalsdrugsfluids and nutrition into the patientthe performance of the medical delivery devicesthe patient's behaviorreaction toconsumption and effectiveness of the pharmaceuticalsdrugsfluids and nutrition provided to the patient via medical delivery devicessold as a unit therewith; drug delivery devices sold emptycatheterspen needlesinjection needlessyringespatchesinfusion pumpspatch pumpswearable injectorshandheld injectors; medical syringes infusion sets; lancets; lancing devices for delivering medication; apparatus delivering pharmaceuticalsmedical pumps and injectors; infusion bolus handle for external patient's activation of the pump; infusion pumps cradles for mounting of infusion pumpscarrying and locking infusion pumps; infusion lock boxes for mounting of infusion pumpscarrying and locking infusion pumps

Publications

History of USPTO decisions and trademark events.

50 publications found

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

04/12/2024

RHRD

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED

02/12/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/06/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/10/2023

FIMP

FINAL DISPOSITION PROCESSED

02/10/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/25/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

11/07/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/25/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

10/25/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/19/2022

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

10/19/2022

GPNX

NOTIFICATION PROCESSED BY IB

08/09/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/09/2022

PUBO

PUBLISHED FOR OPPOSITION

08/09/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/20/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

07/20/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/20/2022

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/07/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/07/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

07/07/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/07/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

07/07/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/07/2022

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

07/06/2022

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

06/21/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/20/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/08/2022

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

06/07/2022

GNFR

FINAL REFUSAL E-MAILED

06/07/2022

CNFR

FINAL REFUSAL WRITTEN

06/07/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/05/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/05/2022

ALIE

ASSIGNED TO LIE

05/05/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/01/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/29/2022

GNRT

NON-FINAL ACTION E-MAILED

04/29/2022

CNRT

NON-FINAL ACTION WRITTEN

04/29/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/30/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/30/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/30/2022

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

11/27/2021

RFNT

REFUSAL PROCESSED BY IB

10/25/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/30/2021

RFRR

REFUSAL PROCESSED BY MPU

09/30/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/16/2021

CNRT

NON-FINAL ACTION WRITTEN

09/15/2021

DOCK

ASSIGNED TO EXAMINER

09/09/2021

MAFR

APPLICATION FILING RECEIPT MAILED

05/22/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/18/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/13/2021

Continuous trademark protection

Get notified about every new filing that threatens EITAN MEDICAL AVOSET or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.